Sriharsha Tella to Incidence
This is a "connection" page, showing publications Sriharsha Tella has written about Incidence.
Connection Strength
0.268
-
Incidence, racial disparities and survival outcomes of mast cell malignancies: analysis from a national database. Leuk Lymphoma. 2018 09; 59(9):2254-2257.
Score: 0.116
-
Incidence, Clinical Features, and Outcomes of Langerhans Cell Sarcoma in the United States. Clin Lymphoma Myeloma Leuk. 2019 07; 19(7):441-446.
Score: 0.032
-
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
Score: 0.032
-
T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes. Br J Haematol. 2019 04; 185(1):140-142.
Score: 0.030
-
Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States. Clin Lymphoma Myeloma Leuk. 2018 07; 18(7):475-479.
Score: 0.030
-
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood. 2018 01 11; 131(2):265-268.
Score: 0.029